Treatment and management of myofascial pain syndrome

Myofascial pain syndrome (MPS) is a major cause of chronic pain affecting millions of people worldwide. It is characterized by trigger points within muscles or fascia that create regional pain patterns. Despite being extremely common — affecting 30-93% of patients seeking care for musculoskeletal pain — MPS remains poorly understood and lacks standardized diagnostic criteria. This creates challenges for healthcare providers trying to diagnose and treat this complex condition effectively.

This comprehensive review examined the current state of knowledge about MPS, including its epidemiology, risk factors, pathophysiology, diagnosis, and treatment options. The authors systematically reviewed published research on various treatment modalities including topical anesthetics, trigger point injections, botulinum toxin type A, acupuncture, kinesiotaping, TENS, and other emerging therapies. They analyzed multiple studies to evaluate the effectiveness of each treatment approach.

MPS affects people of all ages but is most common between ages 27-50, with no clear gender preference. The pathophysiology involves dysfunction at neuromuscular junctions leading to excessive acetylcholine release and muscle contraction. Diagnosis remains challenging due to lack of standardized criteria, though most agree on the presence of trigger points, pain on palpation, referred pain patterns, and local twitch response as key features. Treatment effectiveness varies widely: topical anesthetics showed consistent benefits across studies; trigger point injections with local anesthetics were effective but not superior to dry needling or saline; botulinum toxin results were mixed, with some studies showing benefit while others found no difference from placebo; acupuncture, kinesiotaping, and TENS showed promise, particularly when combined with other therapies.

Patients with MPS have multiple treatment options available, but there is no single "best" approach. The evidence suggests that a multimodal treatment strategy combining different therapies may be most effective. Healthcare providers should start with less invasive options like topical treatments and physical therapy before progressing to more invasive procedures. The lack of standardized diagnostic criteria remains a significant challenge that needs urgent attention from the medical community.

More high-quality research is needed to establish clear treatment guidelines and help clinicians make evidence-based decisions for their patients with MPS.